Literature DB >> 18609565

Correlation study of optimized voxel-based morphometry and (1)H MRS in patients with mesial temporal lobe epilepsy and hippocampal sclerosis.

Milan Brázdil1, Radek Marecek, Dagmar Fojtíková, Michal Mikl, Robert Kuba, Petr Krupa, Ivan Rektor.   

Abstract

PURPOSE: : To assess whether structural and metabolic brain abnormalities are correlated in MTLE/HS syndrome.
METHODS: : Optimized voxel-based morphometry (VBM) of gray matter concentration (GMC) and gray matter volume (GMV) and proton magnetic resonance spectroscopy measurements from both-sided hippocampal and thalamic regions were performed in 20 MTLE/HS patients and 20 sex- and age-matched healthy controls. The local GMC and GMV values were calculated in both the affected and unaffected hippocampi and ipsilateral and contralateral thalami in patients and healthy subjects, and these were compared. VBM variables and NAA, NAA/Cr and NAA/(Cr+Cho) values from the investigated brain regions were correlated.
RESULTS: : (1) Analysis revealed significantly more extensive GMV reduction than GMC reduction in patients' affected hippocampus. In addition, significant GMV reduction was observed in the ipsilateral thalamus in MTLE/HS patients. (2) Significant decreases in all VBM and MRS variables were revealed in the affected hippocampus. Whilst practically normal GMC values were revealed in patients' both-sided thalamic regions, a significant decrease in local GMV and metabolic measurements were found in the patients' ipsilateral thalamus. (3) Pearson's correlations between structural and metabolic abnormalities were significant for the ipsilateral thalamus only.
CONCLUSION: : Structural and metabolic abnormalities as detected by optimized voxel-based morphometry and (1)H MRS in hippocampal and thalamic regions are only partially correlated in MTLE/HS patients. It seems therefore reasonable that both methods reflect different aspects of brain pathology, which, at least to some degree, might be independently ongoing. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18609565      PMCID: PMC6870827          DOI: 10.1002/hbm.20589

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  51 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

2.  Central nervous system trans-synaptic effects of acute axonal injury: a 1H magnetic resonance spectroscopy study.

Authors:  M Rango; D Spagnoli; G Tomei; F Bamonti; G Scarlato; L Zetta
Journal:  Magn Reson Med       Date:  1995-05       Impact factor: 4.668

3.  Topography of interictal glucose hypometabolism in unilateral mesiotemporal epilepsy.

Authors:  S Arnold; G Schlaug; H Niemann; A Ebner; H Lüders; O W Witte; R J Seitz
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

4.  Extrahippocampal temporal lobe atrophy in temporal lobe epilepsy and mesial temporal sclerosis.

Authors:  N F Moran; L Lemieux; N D Kitchen; D R Fish; S D Shorvon
Journal:  Brain       Date:  2001-01       Impact factor: 13.501

5.  Ipsilateral and contralateral thalamic hypometabolism as a predictor of outcome after temporal lobectomy for seizures.

Authors:  A B Newberg; A Alavi; J Berlin; P D Mozley; M O'Connor; M Sperling
Journal:  J Nucl Med       Date:  2000-12       Impact factor: 10.057

6.  Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging.

Authors:  F Cendes; F Andermann; F Dubeau; P M Matthews; D L Arnold
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

7.  Entorhinal cortex MRI assessment in temporal, extratemporal, and idiopathic generalized epilepsy.

Authors:  Neda Bernasconi; Frederick Andermann; Douglas L Arnold; Andrea Bernasconi
Journal:  Epilepsia       Date:  2003-08       Impact factor: 5.864

8.  Medial temporal lobe atrophy in patients with refractory temporal lobe epilepsy.

Authors:  L Bonilha; E Kobayashi; C Rorden; F Cendes; L M Li
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

9.  The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium.

Authors:  P Christiansen; P Toft; H B Larsson; M Stubgaard; O Henriksen
Journal:  Magn Reson Imaging       Date:  1993       Impact factor: 2.546

10.  Cerebellar volumes in newly diagnosed and chronic epilepsy.

Authors:  G Hagemann; L Lemieux; S L Free; K Krakow; A D Everitt; B E Kendall; J M Stevens; S D Shorvon
Journal:  J Neurol       Date:  2002-12       Impact factor: 4.849

View more
  5 in total

1.  Feasibility and reproducibility of neurochemical profile quantification in the human hippocampus at 3 T.

Authors:  Petr Bednařík; Amir Moheet; Dinesh K Deelchand; Uzay E Emir; Lynn E Eberly; Martin Bareš; Elizabeth R Seaquist; Gülin Öz
Journal:  NMR Biomed       Date:  2015-04-22       Impact factor: 4.044

Review 2.  A meta-analysis on progressive atrophy in intractable temporal lobe epilepsy: Time is brain?

Authors:  Lorenzo Caciagli; Andrea Bernasconi; Samuel Wiebe; Matthias J Koepp; Neda Bernasconi; Boris C Bernhardt
Journal:  Neurology       Date:  2017-07-07       Impact factor: 9.910

3.  Intracranial EEG power and metabolism in human epilepsy.

Authors:  J W Pan; H P Zaveri; D D Spencer; H P Hetherington; S S Spencer
Journal:  Epilepsy Res       Date:  2009-08-20       Impact factor: 3.045

4.  Hippocampal involvement in nonpathological déjà vu: Subfield vulnerability rather than temporal lobe epilepsy equivalent.

Authors:  Eva Pešlová; Radek Mareček; Daniel J Shaw; Tomáš Kašpárek; Martin Pail; Milan Brázdil
Journal:  Brain Behav       Date:  2018-06-05       Impact factor: 2.708

5.  Asymmetric Gray Matter Volume Changes Associated with Epilepsy Duration and Seizure Frequency in Temporal-Lobe-Epilepsy Patients with Favorable Surgical Outcome.

Authors:  Jeong Sik Kim; Dae Lim Koo; Eun Yeon Joo; Sung Tae Kim; Dae Won Seo; Seung Bong Hong
Journal:  J Clin Neurol       Date:  2016-07       Impact factor: 3.077

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.